Companies / Aldeyra Therapeutics, Inc. / Activity
Activity — Aldeyra Therapeutics, Inc.
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $219.2K | +130K | 129,693 0.21% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common stock | $98.1K | +46K | 46,044 0.08% of shares | low |
| Q1 2026 as of | Brighton Jones LLC 13F manager | New | Common stock | $37.5K | +22K | 22,199 0.04% of shares | low |
| Q2 2021 as of | Leonteq Securities AG 13F manager | New | Common stock | $34.0K | +3K | 3,000 <0.01% of shares | low |
| Q1 2026 as of | Federated Hermes Inc 13F manager | New | Common stock | $5.0K | +3K | 2,962 <0.01% of shares | low |